Expert Ratings For Amgen
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for Amgen (NASDAQ:AMGN) in the latest quarter, with a blend of bullish and bearish perspectives. The average 12-month price target has increased to $314.55, reflecting a 4.57% rise from the previous target. Key analysts have adjusted their ratings and price targets, indicating evolving sentiments towards Amgen's market performance.
June 14, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have provided mixed ratings for Amgen, with a new average 12-month price target of $314.55, up 4.57% from the previous target. Key analysts have adjusted their ratings and price targets, reflecting evolving sentiments towards Amgen's market performance.
The increase in the average price target and the adjustments by key analysts suggest a positive short-term outlook for Amgen. The mixed ratings indicate some uncertainty, but the overall trend is upward.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100